Preparation of Cationic Immunovesicles Containing Cationic Peptide Lipid for Specific Drug Delivery to Target Cells
Authors:
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 47 (1-3) , 51-57
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesiclesCytotechnology, 2001
- ImmunoliposomesBioDrugs, 2001
- Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)International Journal of Pharmaceutics, 1994
- Lipid-membrane characteristics of large lipid-vesicles prepared by two-step emulsification technique and enzymatic NAD+-recycling in the vesicles.JOURNAL OF CHEMICAL ENGINEERING OF JAPAN, 1993
- Hydrophobic vitamin B12. Part 9. An artificial holoenzyme composed of hydrophobic vitamin B12 and synthetic bilayer membrane for carbon-skeleton rearrangementsJournal of the Chemical Society, Perkin Transactions 2, 1991
- Human-human hybridomas secreting antibodies specific to human lung carcinomaIn Vitro Cellular & Developmental Biology - Plant, 1985
- Hydrophobic Vitamin B12. III. Incorporation of Hydrophobic Vitamin B12 Derivatives into Single-Compartment Vesicles and Their Alkylation in Various Molecular AggregatesBulletin of the Chemical Society of Japan, 1984
- Characterization of molecular aggregates of peptide amphiphiles and kinetics of dynamic processes performed by single-walled vesiclesJournal of the American Chemical Society, 1984
- Preparation of stable single-compartment vesicles with cationic and zwitterionic amphiphiles involving amino acid residuesThe Journal of Organic Chemistry, 1982
- Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.Proceedings of the National Academy of Sciences, 1982